ubs news - Search News

UBS, Credit Suisse

UBS Close to Large Settlement Over Credit Suisse Tax Case

The potential payout relates to an earlier deal over tax evasion by U.S. clients of Credit Suisse, the rival Swiss bank that UBS acquired in 2023.

InvestmentNews · 9h

UBS reportedly close to settling Credit Suisse tax charges with Justice Department

The banking giant is set to pay at least a nine-figure sum over collapsed lender's failure to cooperate with efforts to catch tax-evading clients, according to the Wall Street Journal.

The Globe and Mail · 17h

UBS reportedly nears settlement over Credit Suisse tax evasion case

A U.S. Senate committee found that Credit Suisse violated the plea deal made in 2014 by continuing to help ultra-wealthy Americans evade taxes and concealing more than $700-million from the government

Seeking Alpha on MSN · 13h

UBS poised to pay hundreds of millions over Credit Suisse tax case - report

UBS Group (NYSE:UBS) is close to paying hundreds of millions of dollars for alleged violations by Credit Suisse of an earlier agreement with the U.S. Justice Department regarding U.S. clients who evaded tax,

Business Insider · 17h

UBS set to pay ‘at least hundreds of millions’ in DOJ settlement, WSJ reports

UBS (UBS) is set to pay “at least hundreds of millions of dollars” to settle violations by Credit Suisse of an earlier agreement with the

Novo Nordisk upgraded to Buy from Neutral at UBS

Investopedia on MSN · 1d

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock to "buy" from "neutral," calling the recent sell-off of the stock "overdone.

Business Insider · 1d

Novo Nordisk upgraded to Buy from Neutral at UBS, as CagriSema selloff overdone

UBS analyst upgraded Novo Nordisk (NVO) to Buy from Neutral with a price target of DKK 750, down from DKK 1,100. Novo Nordisk is “well placed”

Fintel on MSN · 1d

UBS Upgrades Novo Nordisk A (NVO)

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst Price Forecast Suggests 61.15% Upside As of December 23, 2024, the average one-year price target for Novo Nordisk A is $137.

13hon MSN

UBS’s stock hit its highest level in 16 years. The good news is the bank is about to get fined hundreds of millions of dollars.

UBS stock reached a new 16-year high after the Wall Street Journal said the bank is about to get fined hundreds of millions ...

15h

Dallas-Based UBS Team Managing $1.5 Billion Specializes In Covering Clients Going Through Transformational Life Events

The women-led team at C2 Advisors has been preparing its clients for market returns in 2025 and favor alternative investments ...

13h

Italy’s Eni Set for €3 Billion Asset Sales in 2025, UBS Says

Eni SpA’s assets selloff plan is more than halfway completed and is far ahead of schedule, according to a UBS report on ...

20h

UBS upgraded to Buy from Hold at Kepler Cheuvreux

Kepler Cheuvreux analyst Nicolas Payen upgraded UBS (UBS) to Buy from Hold with a price target of CHF 33, up from CHF 28.50. The firm says the ...

21h

China's EVs to see self-driving 'democratisation' in 2025, UBS analyst says

Self-driving features will see mass-market adoption in Chinese cars this year, thanks to fierce competition among Chinese ...

UBS Shares Rise as Exane Upgrades on Likely Buyback Increase

UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss ...

National Hockey League41m

UBS Postgame Photos: Islanders 4, Golden Knights 0

Snapshots from the New York Islanders 4-0 win over the Vegas Golden Knights on Thursday, Jan. 9, 2015. Photos by Jeff Bottari ...

10h

Chris Stapleton's 'All-American Road Tour' coming to UBS Arena in Elmont

Country music superstar Chris Stapleton's "All-American Road Show" tour is getting ready to make a stop on Long Island. The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

UBS, Credit Suisse

Novo Nordisk upgraded to Buy from Neutral at UBS

Related topics